• careers
  • investors
  • news
  • suppliers
  • alumni
  • login
    • North, Central, or South America
    • Europe, Middle East, or Africa
    • Japan, Asia, or Austrailia/New Zealand
  • worldwide
    • Argentina
    • Australia
    • Austria
    • Belgium
    • Brazil
    • Canada
    • Chile
    • China
    • Colombia
    • Costa Rica
    • Denmark
    • Ecuador
    • Estonia
    • Finland
    • France
    • Germany
    • Greece
    • Hong Kong
    • Hungary
    • India
    • Ireland
    • Italy
    • Japan
    • Korea
    • Latin America
    • Mexico
    • Netherlands
    • Norway
    • Peru
    • Philippines
    • Russia
    • Singapore
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan
    • Thailand
    • Turkey
    • United Kingdom
    • Venezuela

Eli Lilly and Company

Eli Lilly and Company

  • home
  • about

    About

    Heritage
    Key Facts
    Global Business Areas
    Board of Directors
    Executives
    Corporate Governance
    Business Practices
    Key Issues
    Diversity
    Lilly Foundation
    Lilly Grant Office

    The 10th largest pharmaceutical company in the world, Lilly has remained dedicated to creating medicines that help improve peoples' quality of life for more than 135 years. At the heart of Lilly's operations are its core values - excellence, integrity and respect for people.

    Lilly is about more than creating medicines.

    Key Facts Diversity
  • responsibility

    Responsibility

    Our Approach
    Ethical Business
    Access to Medicines
    Medicine Development
    Workplace
    Communities
    Patients
    Environmental Sustainability

    How Lilly conducts its business is equally as important as the work it does on a daily basis. Lilly's core values - integrity, excellence and respect for people - are reflected in business practices that include strong governance principles, the ethical development of medicines, transparency and ethical product promotion.

    Responsibility is not a fad. It is at the core of who we are.

    Connecting Hearts Abroad Access to Medcines
  • products

    Products

    Human
    Animal
    Patient Safety
    Anti-Counterfeiting

    Lilly's innovative products focus on meeting medical needs in the fields of oncology, cardiovascular, diabetes, critical care, neuroscience, men's health and musculoskeletal. Additionally, Elanco, a division of Eli Lilly and Company, works to provide an equally high standard of quality care and product development for animals.

    Our products help shape patient care worldwide.

    Safety Anti-Counterfeiting
  • r & d

    R & D

    Approach to R&D
    Open Innovation
    Innovation Starts Here
    Global External R&D
    Partnering

    More than 7,300 people comprise Lilly Research Laboratories (LRL), which operates in more than 50 countries worldwide. LRL works to discover and develop innovative therapies for many of the world's unmet medical needs, while also providing ongoing scientific support for marketed products.

    Research is the backbone of Lilly.

    Bioethics Our Pipeline
  • Go SearchAdvanced Search
 

Responsibility

Our Approach
Data Dashboard
Ethical Business
Business Ethics
Public Policy
Supply Chain
Access to Medicines
Health Innovation
The Lilly NCD Partnership
The Lilly MDR-TB Partnership
The Lilly TB Drug Discovery Initiative
Technology Transfer
Moving Forward
Increasing Access to Medicines
Product Donations
Medicine Development
Drug Development Process
Innovative Drug Development
Bioethics Program
Patient Rights in Clinical Trials
Animal Research
Diversity in Clinical Trials
Product Safety
Workplace
Our Workplace
Diversity & Inclusion
Health & Safety
Workplace Awards
Communities
Donations
Connecting Hearts Abroad
Employee Volunteerism
Elanco Giving
Patients
Patient Education
Health Care Professional Education
Environmental Sustainability
Committment & Approach
Product Stewardship
Performance in Operations
Case Study

Copyright © Eli Lilly and Company. All rights reserved.

  • Terms of Use
  • Privacy
  • Sitemap
  • Contact